Systemic Sclerosis

Decreased circulating lymphatic endothelial progenitor cells in digital ulcer-complicated systemic sclerosis
Mirko Manetti, Sara Pratesi, Eloisa Romano, Irene Rosa, Cosimo Bruni, Silvia Bellando-Randone, Serena Guiducci, Enrico Maggi, Lidia Ibba-Manneschi, Marco Matucci-Cerinic

Annals of the Rheumatic Diseases Oct 2018, annrheumdis-2018-214240; DOI: 10.1136/annrheumdis-2018-214240
Patient organisation-led initiatives can play an important role in raising awareness about Raynaud’s phenomenon and encourage earlier healthcare utilisation for high-risk groups
Michael Hughes, Amy Baker, Sue Farrington, John D Pauling

Annals of the Rheumatic Diseases Oct 2018, annrheumdis-2018-214161; DOI: 10.1136/annrheumdis-2018-214161
Slit2/Robo4 axis may contribute to endothelial cell dysfunction and angiogenesis disturbance in systemic sclerosis
Eloisa Romano, Mirko Manetti, Irene Rosa, Bianca Saveria Fioretto, Lidia Ibba-Manneschi, Marco Matucci-Cerinic, Serena Guiducci

Annals of the Rheumatic Diseases Nov 2018, 77 (11) 1665-1674; DOI: 10.1136/annrheumdis-2018-213239
Monocyte and macrophage phenotypes: a look beyond systemic sclerosis
Maurizio Cutolo, Amelia Chiara Trombetta, Stefano Soldano

Annals of the Rheumatic Diseases Sep 2018, annrheumdis-2018-214371; DOI: 10.1136/annrheumdis-2018-214371
M1/M2 polarisation state of M-CSF blood-derived macrophages in systemic sclerosis
Alain Lescoat, Alice Ballerie, Stephane Jouneau, Olivier Fardel, Laurent Vernhet, Patrick Jego, Valérie Lecureur

Annals of the Rheumatic Diseases Sep 2018, annrheumdis-2018-214333; DOI: 10.1136/annrheumdis-2018-214333
Therapeutic interleukin-6 blockade reverses transforming growth factor-beta pathway activation in dermal fibroblasts: insights from the faSScinate clinical trial in systemic sclerosis
Christopher P Denton, Voon H Ong, Shiwen Xu, Haiyin Chen-Harris, Zora Modrusan, Robert Lafyatis, Dinesh Khanna, Angelika Jahreis, Jeffrey Siegel, Thierry Sornasse

Annals of the Rheumatic Diseases Sep 2018, 77 (9) 1362-1371; DOI: 10.1136/annrheumdis-2018-213031
Prediction of progression of interstitial lung disease in patients with systemic sclerosis: the SPAR model
Wanlong Wu, Suzana Jordan, Mike Oliver Becker, Rucsandra Dobrota, Britta Maurer, Håvard Fretheim, Shuang Ye, Elise Siegert, Yannick Allanore, Anna-Maria Hoffmann-Vold, Oliver Distler

Annals of the Rheumatic Diseases Sep 2018, 77 (9) 1326-1332; DOI: 10.1136/annrheumdis-2018-213201
Tracking digital ulcers in systemic sclerosis: a feasibility study assessing lesion area in patient-recorded smartphone photographs
Graham Dinsdale, Tonia L Moore, Joanne B Manning, Andrea K Murray, Ross Atkinson, Karen Ousey, Mark R Dickinson, Christopher Taylor, Ariane L Herrick

Annals of the Rheumatic Diseases Sep 2018, 77 (9) 1382-1384; DOI: 10.1136/annrheumdis-2017-212829
Increase in circulating cells coexpressing M1 and M2 macrophage surface markers in patients with systemic sclerosis
Stefano Soldano, Amelia Chiara Trombetta, Paola Contini, Veronica Tomatis, Barbara Ruaro, Renata Brizzolara, Paola Montagna, Alberto Sulli, Sabrina Paolino, Carmen Pizzorni, Vanessa Smith, Maurizio Cutolo

Annals of the Rheumatic Diseases Jul 2018, annrheumdis-2018-213648; DOI: 10.1136/annrheumdis-2018-213648
Response to: ‘Can we further SPARkle the SPAR model?’ by Kavadichanda et al
Wanlong Wu, Suzana Jordan, Oliver Distler

Annals of the Rheumatic Diseases Jul 2018, annrheumdis-2018-213962; DOI: 10.1136/annrheumdis-2018-213962

Main menu

Systemic Sclerosis

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Systemic Sclerosis

Pages